Entropy Technologies’s Bristol-Myers Squibb BMY Stock Holding History

Entropy Technologies’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$5.96M	Sell	98,252 -164,892	-63%	-$9.61M	0.27%	105
2025 Q4	$14.2M	Buy	263,144 +119,453	+83%	+$5.75M	0.77%	23
2025 Q3	$6.48M	Buy	+143,691	New	+$6.71M	0.48%	42
2024 Q4	–	Sell	-110,022	Closed	-$5.69M	–	741
2024 Q3	$5.69M	Sell	110,022 -26,086	-19%	-$1.22M	0.6%	24
2024 Q2	$5.65M	Buy	+136,108	New	+$6.09M	0.61%	29
2024 Q1	–	Sell	-11,702	Closed	-$600K	–	724
2023 Q4	$600K	Buy	+11,702	New	+$614K	0.11%	304

Other funds holding BMY

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Entropy Technologies's BMY Position: Q1 2026 in Review

Entropy Technologies reduced its Bristol-Myers Squibb (BMY) stake by 63% in Q1 2026, selling an estimated $9.61M and leaving 98,252 shares worth $5.96M. The position accounts for 0.27% of the portfolio, ranked #105.

Entropy Technologies first reported a position in BMY in Q4 2023 and has held it in 6 quarters since. The position peaked at $14.2M in Q4 2025. 2,519 funds tracked by Wall St. Rank hold BMY as of Q1 2026.

Entropy Technologies held 98,252 shares of Bristol-Myers Squibb worth $5.96M as of Q1 2026.
Entropy Technologies sold 164,892 Bristol-Myers Squibb shares in Q1 2026, an estimated $9.61M.
Bristol-Myers Squibb made up 0.27% of Entropy Technologies's portfolio in Q1 2026, its #105 holding.
Entropy Technologies first reported a position in Bristol-Myers Squibb in Q4 2023 and has held it in 6 quarters since.
Entropy Technologies's Bristol-Myers Squibb position peaked at $14.2M in Q4 2025.
2,519 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.

Based on Entropy Technologies's 13F filing for Q1 2026, filed 14 May 2026.